Partial tandem duplication of KMT2A gene in patient afflicted with hypereosinophilic syndrome: A case report


      Eosinophilia is defined as a condition with increased eosinophil cell counts in blood more than the standard value. In this regard, when extensive evaluation fails to reveal the underlying causes of this disease, hypereosinophilic syndrome (HES) diagnosis should be considered. Moreover, it is possible that the mutation of the tyrosine kinase genes, as the most common type of cryptic mutations, is associated with HES syndrome. We report a case of a 47-year-old man who was initially diagnosed with HES by Microscopic examination of bone marrow aspiration and peripheral blood cell analysis. After diagnosis, the patient was administered with cortisone acetate, leading to an initial remission. One month after the initial remission, the disease relapsed, and the patient eventually died. This case report provides the first report of HES, in which a novel variant of partial tandem duplication (PTD) was detected in the KMT2A gene.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cancer Genetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Loules G.
        • Kalala F.
        • Giannakoulas N.
        • Papadakis E.
        • Matsouka P.
        • Speletas M.
        FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia.
        BMC Hematol. 2009; 9: 1
        • Cools J.
        • DeAngelo D.J.
        • Gotlib J.
        • Stover E.H.
        • Legare R.D.
        • Cortes J.
        • Kutok J.
        • Clark J.
        • Galinsky I.
        • Griffin J.D.
        • Cross N.C.
        • Tefferi A.
        • Malone J.
        • Alam R.
        • Schrier S.L.
        • Schmid J.
        • Rose M.
        • Vandenberghe P.
        • Verhoef G.
        • Boogaerts M.
        • Wlodarska I.
        • Kantarjian H.
        • Marynen P.
        • Coutre S.E.
        • Stone R.
        • Gilliland D.G.
        A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.
        N Engl J Med. 2003; 348: 1201-1214
        • Ghasemian Sorbeni F.
        • Montazersaheb S.
        • Ansarin A.
        • Esfahani A.
        • Rezamand A.
        • Sakhinia E.
        Molecular analysis of more than 140 gene fusion variants and aberrant activation of EVI1 and TLX1 in hematological malignancies.
        Ann Hematol. 2017; 96: 1605-1623
        • Choi S.M.
        • Dewar R.
        • Burke P.W.
        • Shao L.
        Partial tandem duplication of KMT2A (MLL) may predict a subset of myelodysplastic syndrome with unique characteristics and poor outcome.
        Haematologica. 2018; 103: e131-e1e4
        • Pallisgaard N.
        • Hokland P.
        • Riishoj D.C.
        • Pedersen B.
        • Jorgensen P.
        Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia.
        Blood. 1998; 92: 574-588
        • Winters A.C.
        • Bernt K.M.
        MLL-rearranged leukemias-an update on science and clinical approaches.
        Front Pediatr. 2017; 5: 4
        • Zhang H.
        • Xiang B.
        • Chen H.
        • Chen X.
        • Cai T.
        A novel deletion mutation in KMT2A identified in a child with ID/DD and blood eosinophilia.
        BMC Med Genet. 2019; 20: 38